BioCentury
ARTICLE | Financial News

Curis completes debt financing

December 17, 2012 8:00 AM UTC

Curis Inc. (NASDAQ:CRIS), Lexington, Mass. Business: Cancer Date completed: 12/12/12 Type: Debt financing Raised: $30 million Investor: Pharmakon Advisors Note: The secured loan bears 12.25% interest....